|
1
|
Massano J, Regateiro FS, Januário G and
Ferreira A: Oral squamous cell carcinoma: Review of prognostic and
predictive factors. Oral Surg Oral Med Oral Pathol Oral Radiol
Endod. 102:67–76. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rajwar YC, Jain N, Bhatia G, Sikka N, Garg
B and Walia E: Expression and Significance of Cadherins and Its
Subtypes in Development and Progression of Oral Cancers: A Review.
J Clin Diagn Res. 9:ZE05–ZE07. 2015.PubMed/NCBI
|
|
3
|
Chang WC, Chang CF, Li YH, Yang CY, Su RY,
Lin CK and Chen YW: A histopathological evaluation and potential
prognostic implications of oral squamous cell carcinoma with
adverse features. Oral Oncol. 95:65–73. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Huang Z, Xie N, Liu H, Wan Y, Zhu Y, Zhang
M, Tao Y, Zhou H, Liu X, Hou J and Wang C: The prognostic role of
tumour-infiltrating lymphocytes in oral squamous cell carcinoma: A
meta-analysis. J Oral Pathol Med. 48:788–798. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kademani D, Bell RB, Schmidt BL,
Blanchaert R, Fernandes R, Lambert P and Tucker WM; American
Association of Oral and Maxillofacial Surgeons Task Force on Oral
Cancer: Oral and maxil-lofacial surgeons treating oral cancer: a
preliminary report from the American Association of Oral and
Maxillofacial Surgeons Task Force on Oral Cancer. J Oral Maxillofac
Surg. 66:2151–2157. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xie Y, Zhong L, Duan D and Li T: Casticin
inhibits invasion and proliferation via downregulation of β-catenin
and reversion of EMT in oral squamous cell carcinoma. J Oral Pathol
Med. 48:897–905. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Staton CA, Brown NJ and Reed MW: Current
status and future prospects for anti-angiogenic therapies in
cancer. Expert Opin Drug Discov. 4:961–979. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bergers G and Benjamin LE: Tumorigenesis
and the angiogenic switch. Nat Rev Cancer. 3:401–410. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Klymkowsky MW and Savagner P:
Epithelial-mesenchymal transition: A cancer researcher's conceptual
friend and foe. Am J Pathol. 174:1588–1593. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang C, Liu X, Chen Z, Huang H, Jin Y,
Kolokythas A, Wang A, Dai Y, Wong DT and Zhou X: Polycomb group
protein EZH2-mediated E-cadherin repression promotes metastasis of
oral tongue squamous cell carcinoma. Mol Carcinog. 52:229–236.
2013. View
Article : Google Scholar
|
|
13
|
Dawei H, Honggang D and Qian W: AURKA
contributes to the progression of oral squamous cell carcinoma
(OSCC) through modulating epithelial-to-mesenchymal transition
(EMT) and apoptosis via the regulation of ROS. Biochem Biophys Res
Commun. 507:83–90. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang J, Zheng G, Zhou L, Li P, Yun M, Shi
Q, Wang T and Wu X: Notch signalling induces epithelial mesenchymal
transition to promote metastasis in oral squamous cell carcinoma.
Int J Mol Med. 42:2276–2284. 2018.PubMed/NCBI
|
|
15
|
Krisanaprakornkit S and Iamaroon A:
Epithelial-mesenchymal transition in oral squamous cell carcinoma.
ISRN Oncol. 2012:6814692012.PubMed/NCBI
|
|
16
|
Espinoza I and Miele L: Deadly crosstalk:
Notch signaling at the intersection of EMT and cancer stem cells.
Cancer Lett. 341:41–45. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Costa LC, Leite CF, Cardoso SV, Loyola AM,
Faria PR, Souza PE and Horta MC: Expression of
epithelial-mesenchymal transition markers at the invasive front of
oral squamous cell carcinoma. J Appl Oral Sci. 23:169–178. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tran Q, Lee H and Park J, Kim SH and Park
J: Targeting Cancer Metabolism - Revisiting the Warburg Effects.
Toxicol Res. 32:177–193. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wu CA, Chao Y, Shiah SG and Lin WW:
Nutrient deprivation induces the Warburg effect through
ROS/AMPK-dependent activation of pyruvate dehydrogenase kinase.
Biochim Biophys Acta. 1833:1147–1156. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sasabe E, Tatemoto Y, Li D, Yamamoto T and
Osaki T: Mechanism of HIF-1alpha-dependent suppression of
hypoxia-induced apoptosis in squamous cell carcinoma cells. Cancer
Sci. 96:394–402. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cheng ZX, Sun B, Wang SJ, Gao Y, Zhang YM,
Zhou HX, Jia G, Wang YW, Kong R, Pan SH, et al: Nuclear
factor-κB-dependent epithelial to mesenchymal transition induced by
HIF-1α activation in pancreatic cancer cells under hypoxic
conditions. PLoS One. 6:e237522011. View Article : Google Scholar
|
|
22
|
Joseph JP, Harishankar MK, Pillai AA and
Devi A: Hypoxia induced EMT: A review on the mechanism of tumor
progression and metastasis in OSCC. Oral Oncol. 80:23–32. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zheng M, Cao MX, Luo XJ, Li L, Wang K,
Wang SS, Wang HF, Tang YJ, Tang YL and Liang XH: EZH2 promotes
invasion and tumour glycolysis by regulating STAT3 and FoxO1
signalling in human OSCC cells. J Cell Mol Med. 23:6942–6954. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liang J, Cao R, Zhang Y, Xia Y, Zheng Y,
Li X, Wang L, Yang W and Lu Z: PKM2 dephosphorylation by Cdc25A
promotes the Warburg effect and tumorigenesis. Nat Commun.
7:124312016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Valentin C, Birgens H, Craescu CT,
Brødum-Nielsen K and Cohen-Solal M: A phosphoglycerate kinase
mutant (PGK Herlev; D285V) in a Danish patient with isolated
chronic hemolytic anemia: Mechanism of mutation and
structure-function relationships. Hum Mutat. 12:280–287. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
He Y, Luo Y, Zhang D, Wang X, Zhang P, Li
H, Ejaz S and Liang S: PGK1-mediated cancer progression and drug
resistance. Am J Cancer Res. 9:2280–2302. 2019.PubMed/NCBI
|
|
27
|
Beutler E: PGK deficiency. Br J Haematol.
136:3–11. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Morales-Briceño H, Ha AD, London K, Farlow
D, Chang FCF and Fung VSC: Parkinsonism in PGK1 deficiency
implicates the glycolytic pathway in nigrostriatal dysfunction.
Parkinsonism Relat Disord. 64:319–323. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hogrel JY, Ledoux I and Béhin A:
Hyperammonaemia following exercise may also reveal PGK1 deficiency.
J Clin Pathol. 72:4522019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Echaniz-Laguna A, Nadjar Y, Béhin A,
Biancalana V, Piraud M, Malfatti E and Laforêt P: Phosphoglycerate
kinase deficiency: A nationwide multicenter retrospective study. J
Inherit Metab Dis. 42:803–808. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
McCarrey JR, Kumari M, Aivaliotis MJ, Wang
Z, Zhang P, Marshall F and Vandeberg JL: Analysis of the cDNA and
encoded protein of the human testis-specific PGK-2 gene. Dev Genet.
19:321–332. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xie H, Tong G, Zhang Y, Liang S, Tang K
and Yang Q: PGK1 Drives Hepatocellular Carcinoma Metastasis by
Enhancing Metabolic Process. Int J Mol Sci. 18:182017. View Article : Google Scholar
|
|
33
|
Shao F, Yang X, Wang W, Wang J, Guo W,
Feng X, Shi S, Xue Q, Gao S, Gao Y, et al: Associations of PGK1
promoter hypomethylation and PGK1-mediated PDHK1 phosphorylation
with cancer stage and prognosis: A TCGA pan-cancer analysis. Cancer
Commun (Lond). 39:542019. View Article : Google Scholar
|
|
34
|
Zhou JW, Tang JJ, Sun W and Wang H: PGK1
facilities cisplatin chemoresistance by triggering HSP90/ERK
pathway mediated DNA repair and methylation in endometrial
endometrioid adenocarcinoma. Mol Med. 25:112019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Balch CM, Gershenwald JE, Soong SJ,
Thompson JF, Atkins MB, Byrd DR, Buzaid AC, Cochran AJ, Coit DG,
Ding S, et al: Final version of 2009 AJCC melanoma staging and
classification. J Clin Oncol. 27:6199–6206. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Goldman M, Craft B, Kamath A, Brooks A,
Zhu J and Haussler D: The UCSC Xena Platform for cancer genomics
data visualization and interpretation. bioRxiv: https://doi.org/10.1101/326470.
2018
|
|
37
|
Wickham H: Tidy Data. J Stat Softw.
59:102014. View Article : Google Scholar
|
|
38
|
Wickham H: ggplot2: Elegant Graphics for
Data Analysis. Springer-Verlag; New York, NY: 2009, View Article : Google Scholar
|
|
39
|
Kassambara A, Kosinski M, Przemyslaw B and
Scheipl F: Drawing survival curves using 'ggplot2'. http://cran.r-project.org/package=survminer.
Accessed May 28, 2020.
|
|
40
|
Wickham H, François R, Henry L and Müller
K; RStudio: dplyr: A Grammar of Data Manipulation. R Package
Version 0.3.0.2. https://cran.r-project.org/web/packages/dplyr/index.html.
Accessed May 29, 2020.
|
|
41
|
Warnakulasuriya S: Living with oral
cancer: Epidemiology with particular reference to prevalence and
life-style changes that influence survival. Oral Oncol. 46:407–410.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Eckert AW, Kappler M, Schubert J and
Taubert H: Correlation of expression of hypoxia-related proteins
with prognosis in oral squamous cell carcinoma patients. Oral
Maxillofac Surg. 16:189–196. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Adeyemi BF and Kolude B: Clinical
presentation of oral squamous cell carcinoma. Niger Postgrad Med J.
20:108–110. 2013.PubMed/NCBI
|
|
44
|
Hsu PP and Sabatini DM: Cancer cell
metabolism: Warburg and beyond. Cell. 134:703–707. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Koppenol WH, Bounds PL and Dang CV: Otto
Warburg's contributions to current concepts of cancer metabolism.
Nat Rev Cancer. 11:325–337. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Chen G, Liu H, Zhang Y, Liang J, Zhu Y,
Zhang M, Yu D, Wang C and Hou J: Silencing PFKP inhibits
starvation-induced autophagy, glycolysis, and epithelial
mesenchymal transition in oral squamous cell carcinoma. Exp Cell
Res. 370:46–57. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Chen MK, Chiou HL, Su SC, Chung TT, Tseng
HC, Tsai HT and Yang SF: The association between hypoxia inducible
factor-1alpha gene polymorphisms and increased susceptibility to
oral cancer. Oral Oncol. 45:e222–e226. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Peerlings J, Van De Voorde L, Mitea C,
Larue R, Yaromina A, Sandeleanu S, Spiegelberg L, Dubois L, Lambin
P and Mottaghy FM: Hypoxia and hypoxia response-associated
molecular markers in esophageal cancer: A systematic review.
Methods. 130:51–62. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Hu X, Lin J, Jiang M, He X, Wang K, Wang
W, Hu C, Shen Z, He Z, Lin H, et al: HIF-1α Promotes the Metastasis
of Esophageal Squamous Cell Carcinoma by Targeting SP1. J Cancer.
11:229–240. 2020. View Article : Google Scholar :
|
|
50
|
Hu H, Zhu W, Qin J, Chen M, Gong L, Li L,
Liu X, Tao Y, Yin H, Zhou H, et al: Acetylation of PGK1 promotes
liver cancer cell proliferation and tumorigenesis. Hepatology.
65:515–528. 2017. View Article : Google Scholar
|
|
51
|
Qian X, Li X and Lu Z: Protein kinase
activity of the glycolytic enzyme PGK1 regulates autophagy to
promote tumorigenesis. Autophagy. 13:1246–1247. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Jang CH, Lee IA, Ha YR, Lim J, Sung MK,
Lee SJ and Kim JS: PGK1 induction by a hydrogen peroxide treatment
is suppressed by antioxidants in human colon carcinoma cells.
Biosci Biotechnol Biochem. 72:1799–1808. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Fu D, He C, Wei J, Zhang Z, Luo Y, Tan H
and Ren C: PGK1 is a potential survival biomarker and invasion
promoter by regulating the HIF-1α-mediated epithelial-mesenchymal
transition process in breast cancer. Cell Physiol Biochem.
51:2434–2444. 2018. View Article : Google Scholar
|
|
54
|
Patel SS, Shah KA, Shah MJ, Kothari KC and
Rawal RM: Cancer stem cells and stemness markers in oral squamous
cell carcinomas. Asian Pac J Cancer Prev. 15:8549–8556. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Mohajertehran F, Sahebkar A, Zare R and
Mohtasham N: The promise of stem cell markers in the diagnosis and
therapy of epithelial dysplasia and oral squamous cell carcinoma. J
Cell Physiol. 233:8499–8507. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Murugan AK, Munirajan AK and Tsuchida N:
Ras oncogenes in oral cancer: The past 20 years. Oral Oncol.
48:383–392. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Lee MS, Jeong MH, Lee HW, Han HJ, Ko A,
Hewitt SM, Kim JH, Chun KH, Chung JY, Lee C, et al: PI3K/AKT
activation induces PTEN ubiquitination and destabilization
accelerating tumourigenesis. Nat Commun. 6:77692015. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Song Y, Zheng S, Wang J, Long H, Fang L,
Wang G, Li Z, Que T, Liu Y, Li Y, et al: Hypoxia-induced PLOD2
promotes proliferation, migration and invasion via PI3K/Akt
signaling in glioma. Oncotarget. 8:41947–41962. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Yu J, Luo Y and Wen Q: Nalbuphine
suppresses breast cancer stem-like properties and
epithelial-mesenchymal transition via the AKT-NFκB signaling
pathway. J Exp Clin Cancer Res. 38:1972019. View Article : Google Scholar
|
